EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Efficacy and tolerability of adjunctive lacosamide in patients aged

Iryna Makedonska, Yu-Tze Ng, Cynthia Beller, Ali Bozorg, János Csikós, Carrie McClung, Holger Moeltgen, Mark Kristof Farkas, SP0967 Study Group

Annals of Clinical and Translational Neurology · 2024

DOI: 10.1002/acn3.52004 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Annals of Clinical and Translational Neurology, 2024. Verfasst von Iryna Makedonska und 8 weiteren Autor:innen. Beteiligte Einrichtung: Municipal Non-profit Enterprise City Children's Clinical Hospital #6 of Dnipro City Council, Dnipro, Ukraine. Hauptthemen laut MEDLINE: Anticonvulsants, Epilepsies, Partial. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UCB Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Primary objective was to evaluate efficacy of lacosamide administered concomitantly with 1–3 antiseizure medications in young children with uncontrolled focal (partial‐onset) seizures.

Methods

Double‐blind, parallel‐group trial (SP0967: NCT02477839/2013‐000717‐20) conducted between June 2015 and May 2020 at hospitals and clinics in 25 countries. Patients (aged ≥1 month to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsEpilepsies, PartialAdultChildHumansChild, PreschoolLacosamideReproducibility of ResultsAcetamidesDrug Therapy, CombinationDose-Response Relationship, DrugTreatment OutcomeSeizures

Substanzen

LacosamideAnticonvulsantsAcetamides

Autor:innen und Institutionen

  • Municipal Non-profit Enterprise City Children's Clinical Hospital #6 of Dnipro City Council, Dnipro, Ukraine.
  • Baylor College of Medicine/The Children's Hospital of San Antonio, San Antonio, Texas, USA.
  • UCB Pharma, Morrisville, North Carolina, USA.
  • UCB Pharma, Monheim am Rhein, Germany.
  • Pediatric Center, MTA Center of Excellence, Semmelweis University, Budapest, Hungary.

Förderung

  • UCB Pharma

Zitieren

APA

Makedonska, I., Ng, Y. T., Beller, C., Bozorg, A., Csikós, J., McClung, C., Moeltgen, H., Farkas, M. K., & SP0967 Study Group (2024). Efficacy and tolerability of adjunctive lacosamide in patients aged. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52004

Vancouver

Makedonska I, Ng YT, Beller C, Bozorg A, Csikós J, McClung C, et al. Efficacy and tolerability of adjunctive lacosamide in patients aged. Annals of Clinical and Translational Neurology. 2024. doi:10.1002/acn3.52004

BibTeX
@article{Makedonska2024,
  author = {Makedonska, Iryna and Ng, Yu-Tze and Beller, Cynthia and Bozorg, Ali and Csikós, János and McClung, Carrie and Moeltgen, Holger and Farkas, Mark Kristof and SP0967 Study Group, SP0967 Study Group},
  title = {Efficacy and tolerability of adjunctive lacosamide in patients aged},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2024},
  doi = {10.1002/acn3.52004}
}
Kostenlos starten →